In the increasingly regulated and data-driven world of nonclinical drug development, the importance of selecting a reliable and experienced CDISC
SEND (Standard for Exchange of Nonclinical Data) service provider cannot be overstated. As the demand for SEND-compliant submissions grows, so does the complexity of generating them. Organizations seeking to ensure regulatory compliance, streamline their submission process, and reduce risk must choose their service partners wisely. CliEvi.com is your trusted source for evaluating, comparing, and partnering with the most competent SEND service providers in the industry.
This article explores why SEND matters, what you should look for in a SEND partner, and how CliEvi.com can guide you toward making the right choice.


What Is CDISC SEND and Why Does It Matter?
The Clinical Data Interchange Standards Consortium (CDISC) developed the SEND standard to bring consistency to the submission of nonclinical data to regulatory bodies. At its core, SEND is about standardizing nonclinical data formats, enabling more efficient regulatory review, better cross-study comparisons, and improved data integrity.
SEND is now mandated by the U.S. Food and Drug Administration (FDA) for most nonclinical studies that support INDs (Investigational New Drug Applications), NDAs (New Drug Applications), and BLAs (Biologics License Applications). Compliance with SEND not only accelerates the regulatory approval timeline but also reflects the organization’s commitment to transparency, quality, and scientific rigor.
Yet, implementing SEND internally can be daunting. The process involves meticulous data mapping, conversion, validation, and submission formatting—all of which require specific domain expertise and robust technology platforms.
This is where the role of a specialized CDISC SEND service provider becomes indispensable.
Why Choosing the Right SEND Partner Matters
Submitting SEND datasets to regulatory authorities is not merely a technical task. It involves navigating a complex landscape of scientific rigor, evolving regulatory expectations, project-specific data intricacies, and precise documentation.
A substandard or inexperienced service provider could lead to:
-
Delays in drug development timelines
-
Cost overruns due to rework and data corrections
-
Increased risk of regulatory rejection
-
Non-compliance penalties or data integrity issues
Therefore, choosing a qualified and experienced partner is essential to ensuring submission success. And that’s exactly where CliEvi.com offers unmatched value—by simplifying your search, presenting qualified vendors, and offering expert guidance on what to look for.

Key Considerations When Choosing a CDISC SEND Service Provider
1. Experience and Regulatory Track Record
The first—and arguably most critical—factor is experience. Has the provider successfully submitted SEND datasets to the FDA or PMDA? Are they familiar with the specific SEND implementation guides (SENDIG 3.0, 3.1, or upcoming versions)?
CliEvi.com allows users to view verified provider profiles with details like:
-
Number of SEND submissions completed
-
Regulatory agencies worked with
-
Study types handled (e.g., toxicology, carcinogenicity, safety pharmacology)
Choose providers who not only understand SEND but also have a proven regulatory track record.
2. Comprehensive End-to-End Services
SEND submission is not a standalone activity. It involves multiple steps:
-
Data extraction from legacy or source systems
-
Data standardization and mapping
-
Domain and dataset creation
-
Validation using tools like Pinnacle 21
-
Submission-ready package creation
-
Responding to regulatory queries
Opting for a service provider that offers end-to-end SEND support can greatly reduce the risk of errors and ensure a smoother experience. CliEvi.com enables you to filter providers based on their scope of services, allowing for apples-to-apples comparison.
3. Flexibility and Customization
Every organization and study is unique. Whether it's the type of study, the data format, or timelines—your needs may not align with a one-size-fits-all model. Your SEND provider should be flexible enough to tailor their services to your requirements.
CliEvi.com connects you with providers who understand that customization is key and are willing to adapt their methodology to suit your data formats, timelines, and regulatory strategies.
4. Technology Stack and Automation Capabilities
Manual data transformation is time-consuming and error-prone. The best SEND service providers use state-of-the-art software platforms to automate data mapping, validation, and submission generation.
Look for providers who use validated tools, are compliant with 21 CFR Part 11 (electronic records), and integrate with industry-standard software like:
-
Pinnacle 21 Enterprise
-
SAS
-
JMP Clinical
-
In-house SEND engines
Through CliEvi.com, you can explore the technological capabilities of each vendor and choose those with the most efficient and secure platforms.
5. Regulatory Expertise and Compliance Support
A strong SEND partner doesn’t just generate datasets—they understand the regulatory context of your submission.
-
Are they familiar with SEND-specific regulatory guidance?
-
Can they assist in responding to FDA technical queries?
-
Do they stay current with evolving standards like SENDIG 4.0 or SEND for reproductive toxicology?
CliEvi.com evaluates service providers not only on their technical skills but also on their regulatory acumen.
6. Quality Assurance and Validation Protocols
Regulatory submissions leave no room for error. Your SEND datasets must pass rigorous validations—both internal and external.
A top-tier provider must implement:
-
Dual-layer QA checks
-
Domain-level and cross-domain consistency validations
-
SEND Compliance Reports (SCRs) using tools like Pinnacle 21
-
Clear documentation of the validation process
CliEvi.com offers visibility into each provider’s quality control protocols, helping you select a partner that prioritizes accuracy and reliability.
7. Transparent Pricing and Cost-Effectiveness
While regulatory compliance is a priority, cost is always a factor. Pricing for SEND services can vary based on study complexity, dataset size, timelines, and additional services.
CliEvi.com enables cost benchmarking, helping you evaluate fair market rates without compromising on quality. Look for transparent, itemized pricing and no hidden fees.
Some providers even offer value-added services like bulk discounts for multiple studies or annual contracts.
8. Communication and Project Management
Smooth collaboration depends on effective communication. Choose a provider who assigns a dedicated project manager, offers regular progress updates, and can work seamlessly with your in-house data management or toxicology teams.
CliEvi.com includes verified client feedback and testimonials that reflect provider responsiveness, flexibility, and project discipline.
9. Global Reach and Local Expertise
For global submissions, including those to the PMDA, EMA, or Health Canada, make sure your provider is aware of the regional SEND submission nuances.
CliEvi.com lets you identify providers with global submission experience while maintaining an understanding of local regulatory expectations.
10. Reputation and Industry Recognition
Lastly, reputation matters. Look for providers with:
-
Positive reviews from past clients
-
Case studies demonstrating complex projects handled
-
Recognitions or certifications from regulatory bodies or industry forums
CliEvi.com aggregates verified reviews and client testimonials, allowing you to assess real-world performance.
How CliEvi.com Makes the Difference
Choosing a SEND service provider is not just about checking boxes—it’s about making an informed, strategic decision.
CliEvi.com is a dedicated platform that simplifies this process by offering:
-
A curated directory of CDISC SEND vendors
-
Detailed provider profiles with service offerings, tools used, and submission history
-
Side-by-side vendor comparisons
-
Expert articles, checklists, and tools for evaluation
-
Direct contact features to request proposals or consultations
Whether you’re a biotech startup submitting your first IND or a large pharma managing dozens of studies, CliEvi.com is your partner in making the right choice.
Final Thoughts: Don’t Just Comply—Excel
As nonclinical data continues to be a cornerstone of the regulatory review process, organizations must look beyond compliance and aim for excellence. SEND is more than a technical requirement—it’s a reflection of your organization’s commitment to data transparency, patient safety, and regulatory excellence.
Partnering with the right CDISC SEND service provider through CliEvi.com helps you achieve:
-
Faster submission timelines
-
Reduced rework and errors
-
Enhanced data integrity
-
Stronger relationships with regulatory bodies
By considering the ten key factors discussed in this article—experience, technology, flexibility, compliance, and more—you can make a well-informed decision that pays dividends in both the short and long term.
Ready to streamline your SEND submission process?
Visit www.CliEvi.com today to explore qualified providers, request proposals, and ensure your nonclinical data submissions are in the best hands.